Condensed Consolidated Statement of Earnings - USD ($) shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Condensed Consolidated Statement of Earnings
Net sales	$ 7,726	$ 7,535
Cost of products sold, excluding amortization of intangible assets	3,281	3,160
Amortization of intangible assets	561	486
Research and development	578	672
Selling, general and administrative	2,548	2,478
Total operating cost and expenses	6,968	6,796
Operating earnings	758	739
Interest expense	139	171
Interest (income)	(18)	(23)
Net foreign exchange (gain) loss	5	6
Other (income) expense, net	(1)	(47)
Earnings from continuing operations before taxes	633	632
Tax expense (benefit) on earnings from continuing operations	89	(40)
Earnings from continuing operations	544	672
Earnings from discontinued operations, net of tax	20
Net Earnings	$ 564	$ 672
Basic Earnings Per Common Share
Continuing operations (in dollars per share)	$ 0.31	$ 0.38
Discontinued operations (in dollars per share)	0.01
Net earnings (in dollars per share)	0.32	0.38
Diluted Earnings Per Common Share
Continuing operations (in dollars per share)	0.30	0.38
Discontinued operations (in dollars per share)	0.01
Net earnings (in dollars per share)	$ 0.31	$ 0.38
Average Number of Common Shares Outstanding Used for Basic Earnings Per Common Share (in shares)	1,768,901	1,763,278
Dilutive Common Stock Options (in shares)	11,677	13,295
Average Number of Common Shares Outstanding Plus Dilutive Common Stock Options (in shares)	1,780,578	1,776,573
Outstanding Common Stock Options Having No Dilutive Effect (in shares)	4,035	4,011